A Patient with Transverse Colon Cancer Complicated by Cowden Syndrome Administered FOLFOXIRI+ Bevacizumab Therapy

K Takehara, Y Ishizaki, K Nagakari, M Ohuchi… - Case Reports in …, 2023 - karger.com
Cowden syndrome is characterized by several clinical features related to tumorous lesions
primarily consisting of systemic hamartomas. The mutation of a tumor suppressor gene, the …

Exploring Better Strategies for RAS Mutation-Associated EGFR-Targeted Resistance in Colorectal Cancer: From the Perspective of Cancer Community Ecology

X Wang, W Wu, Z Zheng, P Chi - Frontiers in Oncology, 2021 - frontiersin.org
RAS is the most common mutated gene in colorectal cancer (CRC), and its occurrence is
associated with primary and acquired resistance to anti-epidermal growth factor receptor …

[HTML][HTML] Role of circulating free DNA in colorectal cancer

A Matikas, A Voutsina, M Trypaki… - World Journal of …, 2016 - ncbi.nlm.nih.gov
The gradual elucidation of the underlying biology of colorectal cancer has provided new
insights and therapeutic options for patients with metastatic disease which are selected …

Genotype-or phenotype-targeting anticancer therapies? Lessons from tumor evolutionary biology

AE Escargueil, S Prado, A Dezaire… - Current …, 2016 - ingentaconnect.com
Despite the efficacy of most cancer therapies, drug resistance remains a major problem in
the clinic. The eradication of the entire tumor and the cure of the patient by chemotherapy …

A trial protocol of precision medicine for patients with RAS wild metastatic colorectal cancer using liquid biopsy (RAS-liquid study): a prospective, multicenter …

A Matsuda, T Yamada, T Takahashi… - Journal of the Anus …, 2022 - jstage.jst.go.jp
Background: Anti-epidermal growth factor receptor (EGFR) therapy has been identified to
prolong the survival of metastatic colorectal cancer (mCRC) patients without RAS mutations …

Report of two patients in whom comparisons of the somatic mutation profile were useful for the diagnosis of metastatic tumors

K Furukawa, K Hatakeyama, M Terashima, K Fujiya… - Surgical Case …, 2022 - Springer
Background When a patient has multiple tumors in different organs, it is very important to
identify whether the tumors are multiple cancers or metastasis from one tumor in order to …

Management of patients with colorectal liver metastasis in eleven questions and answers

A Andres, P Majno, S Terraz, P Morel… - Expert review of …, 2016 - Taylor & Francis
Introduction: Colorectal liver metastasis (CRLM) is the most frequent indication for liver
resection in many centers. Recent improvements in oncology, surgery, interventional …

结直肠癌原发与配对转移肿瘤遗传异质性研究进展

鲁有望, 王昆华 - 遗传, 2017 - chinagene.cn
结直肠癌(colorectal cancer, CRC) 是我国常见的致死性肿瘤类型之一. 根据体细胞突变谱预测
抗EGFR 单抗治疗疗效已成为转移性结直肠癌(metastatic colorectal cancer, mCRC) …

Sequencing of RAS/RAF pathway genes in primary colorectal cancer and matched liver and lung metastases

N Knijn, C van de Water, S van Vliet, J Meijer… - Applied Cancer …, 2019 - Springer
Background Mutations in the RAS/RAF pathway predict resistance to anti-epidermal growth
factor receptor antibodies in colorectal cancer (CRC), and may be targets for future …

[HTML][HTML] Performance of prognostic models incorporating KRAS mutation status to predict survival after resection of colorectal liver metastases

GYM Wong, N Bhimani, B Mol, C Diakos, P de Reuver… - HPB, 2022 - Elsevier
Abstract Background The Genetic And Morphologic Evaluation (GAME) score and modified
clinical score (m-CS) are two novel prognostic models that incorporate KRAS mutation …